Clinical Trials Browser

Phase 2 × Pancreatic Neoplasms × Floxuridine × Clear all

NCT03856658 2025-06-17

Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver Metastases

Phase 2 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal